𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of the combination of bevacizumab with cytotoxic chemotherapy, as first line treatment, in older patients with advanced/metastatic NSCLC (non-squamous)

✍ Scribed by Pallis, A.G.; Vamvakas, L.; Karampeazis, A.; Polyzos, A.; Agelaki, S.; Kentepozidis, N.; Boukovinas, I.; Kotsakis, A.; Papadimitraki, E.; Koinis, F.; Georgoulias, V.


Book ID
122053337
Publisher
Elsevier
Year
2012
Tongue
English
Weight
66 KB
Volume
3
Category
Article
ISSN
1879-4068

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES